Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Fresenius Medical Care AG (NYSE: FMS)
FMS Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
16.40%
Analyst Rating:
STRONG SELL
Analyst Forecast (1yr):
NOT AVAILABLE
FMS Stock Analysis
FMS
PE Ratio:
11.1
FMS
PEG Ratio:
1.2
FMS
Forward EPS Growth (12 month):
9.10%
FMS
PS Ratio:
0.5
FMS
PSG Ratio:
0.1
FMS
Forward Revenue Growth (12 month):
3.70%
FMS Articles
No data was found